ELEV Shares Outstanding History
Below is a table of the ELEV shares outstanding history going back to 6/25/2021:

Date ELEV Shares Outstanding

Also see: ELEV Market Cap History
ELEV Historical Shares Outstanding:
+1.56% CAGR
ELEV Historical Shares Outstanding: +1.56% CAGR

Mouse over chart for data details
6/25/2021 ...10/28/2022
Elevation Oncology is a precision oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Co.'s primary drug development candidate, seribantumab, is an Anti-HER3 monoclonal antibody and potential targeted therapy for solid tumors driven by neuregulin-1, a type of genomic alteration and oncogenic driver, and other receptor tyrosine-protein kinase erbB- (HER3), genomically defined cancers. Co. is also evaluating opportunities for pipeline expansion including prioritizing additional targeted therapy approaches in tumor types defined by genomic driver alterations. We show 7 historical shares outstanding datapoints in our coverage of ELEV's shares outstanding history.

Understanding the changing numbers of ELEV shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ELEV versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ELEV by allowing them to research ELEV shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ELEV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Elevation Oncology (ELEV) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ELGX Shares Outstanding History
ELOX Shares Outstanding History
ELYM Shares Outstanding History
EMBC Shares Outstanding History
EMMA Shares Outstanding History
ENDP Shares Outstanding History
ENOB Shares Outstanding History
ENSG Shares Outstanding History
ENTA Shares Outstanding History
ENVB Shares Outstanding History
More Healthcare companies »


ELEV Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2023, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.